News » MHRA alert » Alert: lercanidipine HCl 20mg tablets
April 22nd 2025
Recordati Pharmaceuticals Limited is recalling one batch of lercanidipine HCl 20mg tablets
The affected batch is
| Batch No. | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| MD4L07 | 01/2028 | 28 | 10/04/2025 |
This is a precautionary measure due to an error in the strength of the product printed on some of the faces (sides) of the product carton. Affected packs of 20mg tablets are incorrectly labelled as 10mg on some sides of the product carton.
Dispensary teams are asked to quarantine all stock and return it to your supplier using your supplier’s approved process.
Patients who have been prescribed 10mg tablets but received the affected batch should contact their GP immediately. Alternatively, such patients can snap the tablet in half across the break line and take half of the tablet.
Patients who have been prescribed 20 mg tablets should continue to take the tablets as prescribed by your doctor.